Latest FrostPharma News & Updates

See the latest news and media coverage for FrostPharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

FrostPharma

Specialty pharmaceutical company

frostpharma.com

Headquarters: Danderyd, Sweden
Founded year: 2010
Company type: Public company
Number of employees: 40–50
Industry: Pharmaceuticals

Last updated October 27

Latest news about FrostPharma

In short: FrostPharma merged with Abboxia, launched new products, and appointed a new CEO.

Company announcements

October 27 FrostPharma

FrostPharma gets interim reimbursement for Midazolam nasal spray in Sweden

The Swedish Dental and Pharmaceutical Benefits Agency granted temporary reimbursement, aiding patients during the standard application assessment phase.

January 14 FrostPharma

FrostPharma launches Silarosa in Norway

The lisdexamfetamine oral solution targets children and adolescents with ADHD, improving adherence and safer treatment. It marks a milestone toward Nordic leadership.

October 13, 2025 FrostPharma

FrostPharma reintroduces DESIVON in Sweden

From October, DESIVON is available at over 1,000 pharmacies in Sweden, including Apoteket AB, Apotek Hjärtat, and Kronans Apotek. The plan is to reach Swedish households.

September 29, 2025 FrostPharma

FrostPharma appoints Magnus Nylén as new CEO

Magnus Nylén comes from Bohus BioTech and has previously been manager at Trimb, Actavis and Karo Healthcare. Fredrik Andersch continues as business development manager and strengthens M&A.

Media coverage

October 6, 2024 Dagens Juridik

Law firm Lindahl has represented the sellers of Abboxia in the strategic merger with FrostPharma. The two companies are now merging under the name FrostPharma and thereby become..

Law firm Lindahl has represented the sellers of Abboxia in the strategic merger with FrostPharma. The two companies are now merging under the name FrostPharma and thereby become...

October 6, 2021 PharmiWeb

Advicenne Announces Commercialization Agreement with FrostPharma AB for Sibnayal™ in the Nordic Region

- Advicenne will receive a transfer price and royalties for an amount markedly higher than 50% of future sales of Sibnayal™ - Sibnayal™ will be...

Never miss news about FrostPharma

Track FrostPharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

FrostPharma competitors & trending companies

Browse news for competitors to FrostPharma and other trending companies.